Meridian
Universe

APGE · CIK 0001974640 · FY2025 live · 2025-12-31

Apogee Therapeutics, Inc.

SafeSEC 10-KClassic ZHealthcare98th percentile in Healthcare · 736 names

View as

Model

Classic Z

FY2025

15.38

Zone

Safe

Prior

Market DD

1y PD

15.38

Z″ 29.53

−21.83.08+

Score 15.38 · distress below 1.80, grey to 2.99, safe at 3.00 and above.

Classic Z factor contributions

  • X1 Working capital / assets

    Short-term liquidity versus the size of the balance sheet.

    0.76
    1.2 × = 0.91
  • X2 Retained earnings / assets

    Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.

    −0.60
    1.4 × = −0.84
  • X3 EBIT / assets

    Operating return on assets. Highest weight in the original model.

    −0.30
    3.3 × = −1.01
  • X4 Book equity / liabilities

    Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.

    27.18
    0.6 × = 16.31
  • X5 Sales / assets

    Asset turnover — how much revenue the asset base supports.

    0.00
    1 × = 0.00

Five-year path

Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.

Overview

rule-v1

Apogee Therapeutics, Inc. is on classic Z at 15.38 (safe) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.

Book screen Safe; market PD —. Tape not priced — not a single default call.

Market DD · naive Merton

No market tape yet.

Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.

Sector peers

Closest Classic Z scores · 98th percentile in Healthcare.

KPI widgets

Current assets

$741M

Total assets

$937M

Current liabilities

$28M

Total liabilities

$33M

Working capital

$713M

Retained earnings

−$562M

EBIT

−$286M

Total sales

$0

Book equity

$904M

Accession 0001974640-26-000002. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 12 Sept 2026.